Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
04 Settembre 2024 - 10:05PM
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative
medicine company focused on the development, manufacture, and
commercialization of product solutions for the Advanced Wound Care
and Surgical & Sports Medicine markets, today announced that
management will participate in the following upcoming investor
conferences:
The Morgan Stanley Global Healthcare
Conference at the New York Marriott Marquis in New York,
NY
- Management will participate in
investor 1x1 meetings. There will be no formal presentation.
The Cantor Fitzgerald Global Healthcare
Conference at the InterContinental Barclay Hotel in New York,
NY
- Management will participate in a
fireside chat on Wednesday, September 18 at 1:20 p.m. Eastern
Time.
A webcast of the conference presentation will be
accessible by visiting the “Upcoming Events” section on the
“Investor Relations” page of Organogenesis’s website
www.organogenesis.com. An archive of the webcast will be available
for replay following the conference for approximately 30 days.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading
regenerative medicine company focused on the development,
manufacture, and commercialization of solutions for the advanced
wound care and surgical and sports medicine markets. Organogenesis
offers a comprehensive portfolio of innovative regenerative
products to address patient needs across the continuum of care. For
more information, visit www.organogenesis.com
Investor Inquiries:
ICR Westwicke
Mike Piccinino, CFA
OrganoIR@westwicke.com
Press and Media Inquiries:
Organogenesis
communications@organo.com
Grafico Azioni Organogenesis (NASDAQ:ORGO)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Organogenesis (NASDAQ:ORGO)
Storico
Da Ott 2023 a Ott 2024